Under what conditions can a pharma company provide financial support for conferences and CME?

Under what conditions can a pharma company provide financial support for conferences and CME?

• A. The grants/contributions are separate from other company funds
• B. The company has had no control over the selection of content, faculty, or venue
• C. Both of the above
• D. The grants must be used for marketing purposes

Answer: (C)

Maintaining independence and transparency in industry-funded CME is essential. When a pharma company provides financial support, the funds should be kept separate from the company’s other funds so the CME activity can be clearly supported as an educational grant rather than as a marketing expense. At the same time, the sponsor should not influence the content, faculty, or venue; decisions about what gets taught, who presents, and where the conference happens should be handled by the independent CME organizers. Why this matters: keeping funds separate helps demonstrate that the money is for education, not promotion, and not blended into marketing budgets. Ensuring no sponsor control over content or speakers preserves objectivity and minimizes bias, which protects the credibility of the CME activity. When both conditions are in place, the funding supports education while maintaining independence. Using the grant for marketing would undermine this independence because it ties the educational activity to promotional aims, which the standards and ethical guidelines seek to avoid. If either condition is missing, the potential for perceived or real bias increases, compromising the integrity of the CME.

Maintaining independence and transparency in industry-funded CME is essential. When a pharma company provides financial support, the funds should be kept separate from the company’s other funds so the CME activity can be clearly supported as an educational grant rather than as a marketing expense. At the same time, the sponsor should not influence the content, faculty, or venue; decisions about what gets taught, who presents, and where the conference happens should be handled by the independent CME organizers.

Why this matters: keeping funds separate helps demonstrate that the money is for education, not promotion, and not blended into marketing budgets. Ensuring no sponsor control over content or speakers preserves objectivity and minimizes bias, which protects the credibility of the CME activity. When both conditions are in place, the funding supports education while maintaining independence.

Using the grant for marketing would undermine this independence because it ties the educational activity to promotional aims, which the standards and ethical guidelines seek to avoid. If either condition is missing, the potential for perceived or real bias increases, compromising the integrity of the CME.